ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 151 filers reported holding ARCUS BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $371,637 | -68.8% | 20,704 | -64.1% | 0.01% | -80.6% |
| Q4 2022 | $1,192,533 | +437.2% | 57,666 | +580.9% | 0.07% | +414.3% |
| Q3 2022 | $222,000 | -50.4% | 8,469 | -52.1% | 0.01% | -12.5% |
| Q2 2022 | $448,000 | -39.2% | 17,690 | -24.3% | 0.02% | -44.8% |
| Q1 2022 | $737,000 | +101.4% | 23,367 | +65.6% | 0.03% | +81.2% |
| Q4 2020 | $366,000 | -38.6% | 14,110 | -59.4% | 0.02% | -42.9% |
| Q3 2020 | $596,000 | – | 34,751 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $28,936,782 | 18.14% |
| Octagon Capital Advisors LP | 1,968,000 | $35,325,600 | 5.43% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $15,612,731 | 5.21% |
| Boxer Capital, LLC | 1,602,200 | $28,759,490 | 1.53% |
| SECTORAL ASSET MANAGEMENT INC | 375,456 | $6,739,435 | 1.31% |
| DAFNA Capital Management LLC | 222,717 | $3,997,770 | 1.24% |
| PFM Health Sciences, LP | 1,405,056 | $25,220,755 | 1.19% |
| Ikarian Capital, LLC | 4,000 | $7,180,000 | 0.86% |
| Capital Impact Advisors, LLC | 24,280 | $435,826 | 0.73% |
| Parkman Healthcare Partners LLC | 205,109 | $3,681,707 | 0.68% |